Well being know-how firm PicnicHealth introduced it’s shifting into the oncology area and teaming up with AstraZeneca to construct a registry to generate real-world knowledge on breast most cancers.
The corporate says it is going to work with individuals dwelling with most cancers to gather and construction their medical information knowledge to advance oncology analysis utilizing strong datasets.
Moreover, the California-based firm introduced a multiyear partnership with biopharmaceutical large AstraZeneca to create a registry to generate longitudinal real-world knowledge from consenting U.S. sufferers identified with stage 1 to stage 3 breast most cancers.
The registry, which sufferers can at present enroll in, will set up their medical information right into a centralized portal and permit sufferers to contribute their de-identified knowledge to breast most cancers analysis.
“We’re best-suited for companions that wish to leverage our expertise working straight with sufferers to develop richer, extra full datasets that supply a window into the affected person expertise for sufferers with early most cancers diagnoses. Since these sufferers are sometimes prone to survive their cancers or stay with most cancers for an prolonged time frame, working with these sufferers to develop datasets performs to our energy in affected person engagement and our means to synthesize affected person information throughout care websites together with patient-reported outcomes,” Dr. Dan Drozd, chief medical officer at PicnicHealth, instructed MobiHealthNews in an electronic mail.
THE LARGER TREND
In April, PicnicHealth introduced a partnership with pharma large Roche and its subsidiary Genentech to speed up neurological illness analysis via investments in real-world knowledge. Roche deliberate to leverage PicnicHealth’s datasets for Alzheimer’s Illness, Alzheimer’s Illness-related dementias and myasthenia gravis, a persistent autoimmune dysfunction leading to weak point of the skeletal muscle tissue.
The identical month, it introduced it might accomplice with international nonprofit firm CureDuchenne, which focuses on discovering a remedy for Duchenne muscular dystrophy. The pair would bolster real-world proof technology for the CureDuchenne Hyperlink platform.
Final 12 months, PicnicHealth scored $60 million in Collection C funding, two years after it secured $35 million in fairness financing.
The info firm additionally introduced a partnership with international biopharmaceutical firm Bristol Myers Squibb to merge datasets to raised perceive sufferers with obstructive hypertrophic cardiomyopathy.
In 2021, PicnicHealth and Komodo Well being shaped a partnership to collectively use their merchandise to create a real-world affected person knowledge pool utilizing de-identified knowledge from payers, suppliers, labs and digital well being information, after which present that knowledge to biopharmaceutical and tutorial communities.
